Javascript must be enabled to use this form.
Department of Health and Human Services, National Institutes of Health, National Institutes of Health (see all US Federal Agencies)
Feb 16, 2005
This Request for Applications (RFA) solicits applications searching for new cellular and genetic markers associated with the origin and progression of myeloproliferative disorders (MPD) that can be applied to the future development of novel therapeutics with curative intent. A separate RFA HL-04-033 (please see http://grants.nih.gov/grants/guide/rfa-files/RFA HL-04-033.html) is directed towards myelodysplastic syndromes. Applicants are directed to apply to one or the other but not both RFAs.
Anyone/General Public City Or Township Governments County Governments Federally Recognized Indian Tribal Governments Independent School Districts Individual/Family Minority Group Native American Organization Non-Government - General Nonprofits Having A 501(C)(3) Status With The IRS, Other Than Institutions Of Higher Education Nonprofits That Do Not Have A 501(C)(3) Status With The IRS, Other Than Institutions Of Higher Education Other Private Institution/Organization Private Institutions Of Higher Education Private Nonprofit Institution/Organization (Includes Institutions Of Higher Education, Hospitals) Profit Organization Public And State Controlled Institutions Of Higher Education Public Housing Authorities/Indian Housing Authorities Small Business (Less Than 500 Employees Special District Governments State (Includes District Of Columbia; Includes Institutions Of Higher Education And Hospitals) U.S. Territories And Possessions (Includes Institutions Of Higher Education, Hospitals)
Blood Diseases and Resources Research Cancer Detection and Diagnosis Research
http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-04-034.html
If you have problems accessing the full announcement, please contact: NIH OER Webmaster